Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness

Abstract

Sepsis is associated with impaired muscle function but the role of glucocorticoids in sepsis-induced muscle weakness is not known. We tested the role of glucocorticoids in sepsis-induced muscle weakness by treating septic rats with the glucocorticoid receptor antagonist RU38486. In addition, normal rats were treated with dexamethasone to further examine the role of glucocorticoids in the regulation of muscle strength. Sepsis was induced in rats by cecal ligation and puncture, and muscle force generation (peak twitch and tetanic tension) was determined in lower extremity muscles. In other experiments, absolute and specific force as well as stiffness (reflecting the function of actomyosin cross bridges) were determined in isolated skinned muscle fibers from control and septic rats. Sepsis and treatment with dexamethasone resulted in reduced maximal twitch and tetanic force in intact isolated extensor digitorum longus muscles. The absolute and specific maximal force in isolated muscle fibers was reduced during sepsis together with decreased fiber stiffness. These effects of sepsis were blunted (but not abolished) by RU38486. The results suggest that muscle weakness during sepsis is at least in part regulated by glucocorticoids and reflects loss of contractility at the cellular (individual muscle fiber) level. In addition, the results suggest that reduced function of the cross bridges between actin and myosin (documented as reduced muscle fiber stiffness) may be involved in sepsis-induced muscle weakness. An increased understanding of mechanisms involved in loss of muscle strength will be important for the development of new treatment strategies in patients with this debilitating consequence of sepsis.

The diaphragm is better protected from oxidative stress than hindlimb skeletal muscle during CLP-induced sepsis

“…[6,7] Moreover, differences between limb muscles are also reported in rodent experimental models of sepsis with a pronounced decrease in muscle strength and release in myofilaments in glycolytic compared to oxidative skeletal muscles. [5,8,9] Altogether, these data highlight that skeletal muscles are differently impacted by systemic inflammation during sepsis depending on function, contractile activity, and metabolic profile. However, the underlying molecular mechanisms remain poorly understood.…”

Pyropia yezoensis Protein Prevents Dexamethasone-Induced Myotube Atrophy in C2C12 Myotubes

“…Among them, many pathological conditions are associated with increased circulating levels of glucocorticoids (GCs), which cause muscle atrophy. Recent studies have shown that sepsis-induced muscle atrophy is induced by a reduction in function of the cross-bridges between actin and myosin, which is at least partially regulated by GCs [4].…”

ChronicPseudomonas aeruginosaInfection and Respiratory Muscle Impairment in Cystic Fibrosis

“…6,7 Chronic infection has been linked to compromised diaphragm function in animal models 8 and human patients. 9 Respiratory failure in CF is caused by parenchyma destruction, recurrent infection, and bronchiectasis, and respiratory muscle dysfunction might also play a critical role. Respiratory muscle compromise in CF can lead to respiratory muscle fatigue and thus contribute to respiratory failure.…”